Abstract
IntroductionTreatment of hepatitis C virus (HCV) with pegylated interferon and ribavirin achieves a sustained viral response (SVR) in 40%–50% of genotype 1 patients.1 Protease inhibitors (PIs) increase SVR rates in...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have